Objective To make recommendations on how to report disease activity in clinical trials of
rheumatoid arthritis (RA) endorsed by the European League Against Rheumatism (EULAR) …

Objective. To develop a set of disease activity measures for use in rheumatoid arthritis (RA)
clinical trials, as well as to recommend specific methods for assessing each outcome …

FOR many years disease activity in rheumatoid arthritis (RA) has been measured by an
enormous number of different variables as a single golden standard for measuring disease …

Objectives: Patient-reported outcomes (PROs) have been increasingly recognised as
important in rheumatoid arthritis (RA). The objective of this study was to assess the …

Aim To measure the level of agreement and application of 10 international
recommendations for treating rheumatoid arthritis (RA) to a target of remission/low disease …

Background. Recent randomized controlled trials (RCTs) in rheumatoid arthritis (RA) have
used patient-and physician-reported outcomes, ESR and/or CRP as components of ACR …

Objective. Trials of rheumatoid arthritis (RA) treatments report the average response in
multiple outcome measures for treated patients. It is more clinically relevant to test whether …

There is a growing interest in patient-reported outcomes (PROs) in rheumatology, which
goes with a global trend for more 'patient-centred care'. This review considers the use of …

There is no single 'gold standard'quantitative measure to assess and monitor the clinical
status in patients with rheumatoid arthritis (RA). Therefore, a variety of measures have been …

Objective To develop recommendations to enable successful inclusion of the patient
perspective in European League Against Rheumatism (EULAR)-funded scientific research …